Tengjun Biotechnology (TJBH) 10-K 7 Mar 18 2017 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2017	Mar. 07, 2018	Jun. 30, 2017
Document and Entity Information [Abstract]
Entity Registrant Name	China Herb Group Holdings Corp
Entity Central Index Key	1,499,785
Trading Symbol	CHGH
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Type	10-K
Document Period End Date	Dec. 31, 2017
Document Fiscal Year Focus	2,017
Document Fiscal Period Focus	FY
Entity Filer Category	Smaller Reporting Company
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	Yes
Entity Current Reporting Status	Yes
Entity Public Float			$ 68,223,168
Entity Common Stock, Shares Outstanding		38,136,540

Balance Sheets

Balance Sheets - USD ($)	Dec. 31, 2017	Dec. 31, 2016
CURRENT ASSETS:
Cash and cash equivalents
Prepaid expenses	3,333	4,367
TOTAL CURRENT ASSETS	3,333	4,367
TOTAL ASSETS	3,333	4,367
CURRENT LIABILITIES:
Accounts payable and accrued liabilities	11,000	11,361
Advances for common stock purchases	2,937
Related party loans	204,645	195,072
TOTAL CURRENT LIABILITIES	218,582	206,433
STOCKHOLDERS' DEFICIT:
Preferred stock ($.001 par value; 5,000,000 shares authorized; 0 shares issued and outstanding)
Common stock ($.001 par value; 70,000,000 shares authorized; 38,136,540 and 37,493,120 shares issued and outstanding at December 31, 2017 and 2016, respectively)	38,137	37,493
Additional paid-in capital	162,815	128,411
Accumulated deficit	(416,201)	(367,970)
TOTAL STOCKHOLDERS' DEFICIT	(215,249)	(202,066)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$ 3,333	$ 4,367

Balance Sheets (Parenthetical)

Balance Sheets (Parenthetical) - $ / shares	Dec. 31, 2017	Dec. 31, 2016
Statement of Financial Position [Abstract]
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	70,000,000	70,000,000
Common stock, shares issued	38,136,540	37,493,120
Common stock, shares outstanding	38,136,540	37,493,120

Statements of Operations

Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Income Statement [Abstract]
Revenues
Operating Expenses:
General and administrative	17,320	18,033
Accounting fees	13,650	13,350
Transfer agent fees	1,516	5,440
Total Operating Expenses	32,486	36,823
Loss from Operations	(32,486)	(36,823)
Other Expense:
Interest expense - related parties	(15,745)	(13,841)
Other expense		(10,000)
Total Other Expense	(15,745)	(23,841)
Net Loss	$ (48,231)	$ (60,664)
Net loss per common share, basic and diluted	$ (0.001)	$ (0.002)
Weighted average number of common shares outstanding:
Basic and diluted	37,746,962	36,841,890

Statements of Stockholders' Def

Statements of Stockholders' Deficit - USD ($)	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit
Balance at Dec. 31, 2015	$ (156,293)	$ 36,443	$ 114,570	$ (307,306)
Balance, shares at Dec. 31, 2015		36,443,119
Common stock sold for cash	1,050	$ 1,050
Common stock sold for cash, shares		1,050,001
Imputed interest	13,841		13,841
Net loss	(60,664)			(60,664)
Balance at Dec. 31, 2016	(202,066)	$ 37,493	128,411	(367,970)
Balance, shares at Dec. 31, 2016		37,493,120
Common stock sold for cash	19,303	$ 644	18,659
Common stock sold for cash, shares		643,420
Imputed interest	15,745		15,745
Net loss	(48,231)			(48,231)
Balance at Dec. 31, 2017	$ (215,249)	$ 38,137	$ 162,815	$ (416,201)
Balance, shares at Dec. 31, 2017		38,136,540

Statements of Cash Flow

Statements of Cash Flow - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Loss	$ (48,231)	$ (60,664)
Adjustments to reconcile net loss to net cash used in operating activities:
Imputed interest on related parties loans	15,745	13,841
Changes in operating assets and liabilities:
Decrease (increase) in prepaid expenses	1,034	(4,367)
(Decrease) increase in accounts payable and accrued liabilities	(361)	7,021
NET CASH USED IN OPERATING ACTIVITIES	(31,813)	(44,169)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds received as advance for future common stock subscriptions	2,937
Proceeds from sale of common stock	19,303	1,050
Proceeds received from loans from officer	31,813	41,324
Repayments made for loans from officer	(22,240)
NET CASH PROVIDED BY FINANCING ACTIVITIES	31,813	42,374
NET DECREASE IN CASH		(1,795)
Cash, beginning of year		1,795
Cash, end of year
SUPPLEMENTAL DISCLOSURES:
Interest paid
Income taxes paid

Organization

Organization	12 Months Ended
	Dec. 31, 2017
Organization [Abstract]
ORGANIZATION	NOTE 1 – ORGANIZATION China Herb Group Holdings Corporation (the “Company”) was incorporated under the name “Island Radio, Inc” under the laws of the State of Nevada on June 28, 2010. On June 27, 2012, Eric R. Boyer and Nina Edstrom (collectively, the “Sellers”), who were then the major shareholders of the Company, entered into a Share Purchase Agreement with Chin Yung Kong, Qiuping Lu and Fumin Feng (collectively, the “Purchasers”), pursuant to which the Sellers sold to the Purchasers an aggregate 4,000,000 shares of the common stock of the Company, which represented approximately 93% of the then total issued and outstanding stock of the Company, for a total purchase price of $159,970 (the “Change in Control”). As result of this share purchase transaction, Chin Yung Kong, Qiuping Lu and Fumin Feng became the controlling shareholders of the Company. The Company’s original business plan was to become a commercial FM radio broadcaster. Subsequently, following the Change in Control, the Company changed its business plan and intended to become a medical and spa company with a focus on Asia. However, after consultation with its professional and business advisors in the United States and the People’s Republic of China, the Company’s management decided during the third quarter of 2014 that this would no longer be its plan of operations. The Company’s plan of operations is to evaluate various industries, geographic and market opportunities. This may take the form of acquiring a business, being acquired by an existing business or developing a business organically. Any such efforts may require significant capital, which the Company currently lacks. There is no assurance that any such opportunity will become available. There is also no assurance that, if any opportunity becomes available, the Company will have the financial and other resources available to take advantage of such opportunity, since the Company’s has extremely limited liquidity. Through December 31, 2017, the Company has no revenues or operation.

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2017
Summary of Significant Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying financial statements for China Herb Group Holdings Corporation have been prepared in accordance with accounting principles generally accepted in the United States of America and in accordance with Regulation S-X promulgated by the Securities and Exchange Commission. Use of Estimates The accompanying financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America. Because a precise determination of many assets and liabilities is dependent upon future events, the preparation of financial statements for a period necessarily involves the use of estimates which have been made using careful judgment. Actual results may vary from these estimates. Fair Value of Financial Instruments ASC 820, “Fair Value Measurements” and ASC 825, Financial Instruments, requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. It establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. It prioritizes the inputs into three levels that may be used to measure fair value : Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities . Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data . Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities . As of December 31, 2017 and 2016, the Company believes that the recorded values of all of its financial instruments approximate their current fair values because of their nature and respective maturity dates or durations . Description Level 1 Level 2 Level 3 Total Realized Loss December 31, 2017 - - - - December 31, 2016 - - - - Total - - - - ASC 825-10 “Financial Instruments”, allows entities to voluntarily choose to measure certain financial assets and liabilities at fair value (fair value option). The fair value option may be elected on an instrument-by-instrument basis and is irrevocable, unless a new election date occurs. If the fair value option is elected for an instrument, unrealized gains and losses for that instrument should be reported in earnings at each subsequent reporting date. The Company did not elect to apply the fair value option to any outstanding instruments. Cash and Cash Equivalents For purposes of the statement of cash flows, the Company considers highly liquid financial instruments purchased with a maturity of three months or less to be cash equivalents. As of December 31, 2017 and 2016, the Company had no cash equivalents. Prepaid Expenses Prepaid expenses relate to cash paid in advance for annual listing fee. These amounts are recognized as expense over the related listing periods. At December 31, 2017 and 2016, prepaid expenses amounted $3,333 and $4,367, re spectively. Advances for Common Stock Purchases Advances for common stock purchases consist of prepayments from investors for the purchase of common stock prior to the signing of a stock subscription agreement. The Company reclassified to equity the advances for common stock purchases at the time the stock subscription was signed. At December 31, 2017 and 2016, the Company had advances for common stock purchases of $2,937 and $0, respectively. Income Taxes Deferred income tax assets and liabilities arise from temporary differences associated with differences between the financial statements and tax basis of assets and liabilities, as measured by the enacted tax rates, which are expected to be in effect when these differences reverse. Deferred tax assets and liabilities are classified as current or non-current, depending upon the classification of the assets or liabilities to which they relate. Deferred tax assets and liabilities not related to an asset or liability are classified as current or non-current depending on the periods in which the temporary differences are expected to reverse. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. The Company follows the provisions of Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 740-10 “Uncertainty in Income Taxes” (ASC 740-10). Certain recognition thresholds must be met before a tax position is recognized in the financial statements. An entity may only recognize or continue to recognize tax positions that meet a "more-likely-than-not" threshold. As of December 31, 2017 and 2016, the Company does not believe it has any uncertain tax positions that would require either recognition or disclosure in the accompanying financial statements. Loss per Share Calculation Basic net loss per common share is computed by dividing the net loss attributable to common stockholders by the weighted-average number of common shares outstanding for the period. Diluted earnings per shares is computed similar to basic loss per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. During the years ended December 31, 2017 and 2016, the Company had no dilutive financial instruments issued or outstanding. Recent Accounting Pronouncements Accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.

Going Concern

Going Concern	12 Months Ended
	Dec. 31, 2017
Going Concern [Abstract]
GOING CONCERN	NOTE 3 - GOING CONCERN The Company has minimal operations, and as such has devoted most of its efforts since its inception to developing its business plan, issuing common stock, attempting to raise capital, establishing its accounting systems and other administrative functions. As of December 31, 2017, the Company had $0 in cash and has been funding its working capital needs from loans from related parties. The Company is seeking sources of funding. Without limiting its available options, future equity financings will most likely be through the sale of additional shares of its common stock. It is possible that the Company could also offer warrants, options and/or rights in conjunction with any future issuances of its common stock. However, the Company can give no assurance that financing will be available to it, and if available, in amounts or on terms acceptable to the Company。 The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, which contemplate continuation of the Company as a going concern. The Company has not established a source of revenues sufficient to cover its operating costs, and as such, has incurred an operating loss since its inception. Further, as of December 31, 2017, the Company had a working capital deficit, accumulated deficit and stockholders’ deficit of $215,249, $416,201 and $215,249, respectively. These and other factors raise substantial doubt about the Company’s ability to continue as a going concern. The accompanying financial statements do not include any adjustments or classifications that may result from the possible inability of the Company to continue as a going concern.

Related Parties Transactions

Related Parties Transactions	12 Months Ended
	Dec. 31, 2017
Related Parties Transactions [Abstract]
RELATED PARTIES TRANSACTIONS	NOTE 4 - RELATED PARTIES TRANSACTIONS Related Parties Loans In year 2013, Chin Yung Kong, the director and shareholder of the Company, advanced $20,000 to the Company for working capital purposes. These working capital advances of $20,000 are payable on demand and, at December 31, 2017 and 2016, reflected as related party loans on the accompanying balance sheets. Starting from year 2014, Qiuping Lu, President, CEO, director and shareholder of the Company, advanced funds to the Company for working capital purposes. These working capital advances are payable on demand. As of December 31, 2017 and 2016, these working capital advances amounted to $184,645 and $175,072, respectively, are reflected as related party loans on the accompanying balance sheets. The Company made repayments of $22,240 to Qiuping Lu in 2017. During the years ended December 31, 2017 and 2016, in connection with these related party loans, the Company imputed interest of $15,745 and $13,841, respectively, and recorded interest expense and an increase in additional paid-in capital. Office Space from Related Party The Company uses office space of a related party, free of rent, which is considered immaterial.

Stockholders' Equity (Deficit)

Stockholders' Equity (Deficit)	12 Months Ended
	Dec. 31, 2017
Stockholders' Equity (Deficit) [Abstract]
STOCKHOLDERS' EQUITY (DEFICIT)	NOTE 5 – STOCKHOLDERS’ EQUITY (DEFICIT) Preferred Stock The total number of preferred shares authorized that may be issued by the Company is 5,000,000 shares with a par value of $0.001 per share. As of December 31, 2017 and 2016, the Company had no shares of its preferred stock issued and outstanding. Common Stock The total number of common shares authorized that may be issued by the Company is 70,000,000 shares with a par value of $0.001 per share. As of December 31, 2017 and 2016, the Company had 38,136,540 and 37,493,120 shares of its common stock issued and outstanding, respectively. Common Stock Sold for Cash On August 15, 2016, the Company sold 1,050,001 shares of common stock at a purchase price of $0.001 per share to 28 investors pursuant to a stock purchase agreement. The Company did not engage a placement agent with respect to the sale. The Company received proceeds of $1,050. On August 10, 2017, the Company sold 643,420 shares of common stock at a purchase price of $0.03 per share to several investors pursuant to a stock purchase agreement. The Company did not engage a placement agent with respect to the sale. The Company received proceeds of $19,303.

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2017
Income Taxes [Abstract]
INCOME TAXES	NOTE 6 – INCOME TAXES The Company maintains deferred tax assets and liabilities that reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The deferred tax assets at December 31, 2017 and 2016 consist of net operating loss carryforwards. The net deferred tax asset has been fully offset by a valuation allowance because of the uncertainty of the attainment of future taxable income. The items accounting for the difference between income taxes at the effective statutory rate and the provision for income taxes for the years ended December 31, 2017 and 2016 were as follows: Year Ended Year Ended December 31, 2017 December 31, 2016 Income tax benefit at U.S. statutory rate of 35% $ (16,881 ) $ (21,232 ) Non-deductible interest 5,510 4,844 Change in valuation allowance 11,371 16,388 Total provision for income tax $ - $ - The Company’s approximate net deferred tax asset as of December 31, 2017 and 2016 was as follows: Deferred Tax Asset: December 31, 2017 December 31, 2016 Net operating loss carryforward $ 122,537 $ 111,166 Valuation allowance (122,537 ) (111,166 ) Net deferred tax asset $ - $ - The net operating loss carryforward was $350,105 at December 31, 2017. The Company provided a valuation allowance equal to the deferred income tax asset for the years ended December 31, 2017 and 2016 because it was not known whether future taxable income will be sufficient to utilize the loss carryforward. The increase in the allowance was $11,371 in 2017. The potential tax benefit arising from the loss carryforward will expire in 2037 . Additionally, the future utilization of the net operating loss carryforward to offset future taxable income may be subject to an annual limitation as a result of ownership changes that could occur in the future. If necessary, the deferred tax assets will be reduced by any carryforward that expires prior to utilization as a result of such limitations, with a corresponding reduction of the valuation allowance . The Company does not have any uncertain tax positions or events leading to uncertainty in a tax position .

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2017
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 7 - SUBSEQUENT EVENTS The Company has evaluated subsequent events from the balance sheet date through the date the financial statements were issued and has determined there are no additional events required to be disclosed .

Summary of Significant Accoun14

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2017
Summary of Significant Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying financial statements for China Herb Group Holdings Corporation have been prepared in accordance with accounting principles generally accepted in the United States of America and in accordance with Regulation S-X promulgated by the Securities and Exchange Commission.
Use of Estimates	Use of Estimates The accompanying financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America. Because a precise determination of many assets and liabilities is dependent upon future events, the preparation of financial statements for a period necessarily involves the use of estimates which have been made using careful judgment. Actual results may vary from these estimates.
Fair Value of Financial Instruments	Fair Value of Financial Instruments ASC 820, “Fair Value Measurements” and ASC 825, Financial Instruments, requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. It establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. It prioritizes the inputs into three levels that may be used to measure fair value : Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities . Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data . Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities . As of December 31, 2017 and 2016, the Company believes that the recorded values of all of its financial instruments approximate their current fair values because of their nature and respective maturity dates or durations . Description Level 1 Level 2 Level 3 Total Realized Loss December 31, 2017 - - - - December 31, 2016 - - - - Total - - - - ASC 825-10 “Financial Instruments”, allows entities to voluntarily choose to measure certain financial assets and liabilities at fair value (fair value option). The fair value option may be elected on an instrument-by-instrument basis and is irrevocable, unless a new election date occurs. If the fair value option is elected for an instrument, unrealized gains and losses for that instrument should be reported in earnings at each subsequent reporting date. The Company did not elect to apply the fair value option to any outstanding instruments.
Cash and Cash Equivalents	Cash and Cash Equivalents For purposes of the statement of cash flows, the Company considers highly liquid financial instruments purchased with a maturity of three months or less to be cash equivalents. As of December 31, 2017 and 2016, the Company had no cash equivalents.
Prepaid Expenses	Prepaid Expenses Prepaid expenses relate to cash paid in advance for annual listing fee. These amounts are recognized as expense over the related listing periods. At December 31, 2017 and 2016, prepaid expenses amounted $3,333 and $4,367, re spectively.
Advances for Common Stock Purchases	Advances for Common Stock Purchases Advances for common stock purchases consist of prepayments from investors for the purchase of common stock prior to the signing of a stock subscription agreement. The Company reclassified to equity the advances for common stock purchases at the time the stock subscription was signed. At December 31, 2017 and 2016, the Company had advances for common stock purchases of $2,937 and $0, respectively.
Income Taxes	Income Taxes Deferred income tax assets and liabilities arise from temporary differences associated with differences between the financial statements and tax basis of assets and liabilities, as measured by the enacted tax rates, which are expected to be in effect when these differences reverse. Deferred tax assets and liabilities are classified as current or non-current, depending upon the classification of the assets or liabilities to which they relate. Deferred tax assets and liabilities not related to an asset or liability are classified as current or non-current depending on the periods in which the temporary differences are expected to reverse. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. The Company follows the provisions of Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 740-10 “Uncertainty in Income Taxes” (ASC 740-10). Certain recognition thresholds must be met before a tax position is recognized in the financial statements. An entity may only recognize or continue to recognize tax positions that meet a "more-likely-than-not" threshold. As of December 31, 2017 and 2016, the Company does not believe it has any uncertain tax positions that would require either recognition or disclosure in the accompanying financial statements.
Loss per Share Calculation	Loss per Share Calculation Basic net loss per common share is computed by dividing the net loss attributable to common stockholders by the weighted-average number of common shares outstanding for the period. Diluted earnings per shares is computed similar to basic loss per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. During the years ended December 31, 2017 and 2016, the Company had no dilutive financial instruments issued or outstanding.
Recent Accounting Pronouncements	Recent Accounting Pronouncements Accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.

Summary of Significant Accoun15

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2017
Summary of Significant Accounting Policies [Abstract]
Summary of financial instruments current fair values	Description Level 1 Level 2 Level 3 Total Realized Loss December 31, 2017 - - - - December 31, 2016 - - - - Total - - - -

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2017
Income Taxes [Abstract]
Summary of difference between income taxes at the effective statutory rate and the provision for income taxes	Year Ended Year Ended December 31, 2017 December 31, 2016 Income tax benefit at U.S. statutory rate of 35% $ (16,881 ) $ (21,232 ) Non-deductible interest 5,510 4,844 Change in valuation allowance 11,371 16,388 Total provision for income tax $ - $ -
Summary of net deferred tax asset	Deferred Tax Asset: December 31, 2017 December 31, 2016 Net operating loss carryforward $ 122,537 $ 111,166 Valuation allowance (122,537 ) (111,166 ) Net deferred tax asset $ - $ -

Organization (Details)

Organization (Details) - USD ($)	Aug. 15, 2016	Jun. 27, 2012	Dec. 31, 2017	Dec. 31, 2016
Organization (Textual)
Sellers sold to purchasers an aggregate shares of common stock	1,050,001	4,000,000
Percentage of company common stock issued and outstanding		93.00%
Total purchase price		$ 159,970	$ 19,303	$ 1,050

Summary of Significant Accoun18

Summary of Significant Accounting Policies (Details) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total Realized Loss
Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total Realized Loss
Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total Realized Loss
Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total Realized Loss

Summary of Significant Accoun19

Summary of Significant Accounting Policies (Details Textual) - USD ($)	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Summary of Significant Accounting Policies (Textual)
Cash equivalents			$ 1,795
Prepaid expenses	3,333	4,367
Advances for common stock purchases	$ 2,937

Going Concern (Details)

Going Concern (Details) - USD ($)	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Going Concern (Textual)
Cash			$ 1,795
Working capital deficit	215,249
Accumulated deficit	(416,201)	(367,970)
Stockholders' deficit	$ (215,249)	$ (202,066)	$ (156,293)

Related Parties Transactions (D

Related Parties Transactions (Details) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2013
Related Parties Transactions (Textual)
Due to related parties	$ 204,645	$ 195,072
Imputed interest	15,745	13,841
Repayments of related party debt	22,240
Qiuping Lu [Member]
Related Parties Transactions (Textual)
Due to related parties	184,645	175,072
Repayments of related party debt	22,240
Chin Yung Kong [Member]
Related Parties Transactions (Textual)
Due to related parties	$ 20,000	$ 20,000	$ 20,000

Stockholders' Equity (Deficit)

Stockholders' Equity (Deficit) (Details)	Aug. 10, 2017USD ($)$ / sharesshares	Aug. 15, 2016USD ($)Individuals$ / sharesshares	Jun. 27, 2012shares	Dec. 31, 2017USD ($)$ / sharesshares	Dec. 31, 2016USD ($)$ / sharesshares
Stockholders' Equity (Deficit) (Textual)
Preferred stock, shares authorized				5,000,000	5,000,000
Preferred stock, par value | $ / shares				$ 0.001	$ 0.001
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, shares authorized				70,000,000	70,000,000
Common stock, par value | $ / shares				$ 0.001	$ 0.001
Common stock, shares issued				38,136,540	37,493,120
Common stock, shares outstanding				38,136,540	37,493,120
Common stock sold to several investors		1,050,001	4,000,000
Common stock at purchase price per share | $ / shares		$ 0.001
Number of investors | Individuals		28
Proceeds of common stock | $	$ 19,303	$ 1,050		$ 19,303	$ 1,050
Several Investors [Member]
Stockholders' Equity (Deficit) (Textual)
Common stock sold to several investors	643,420
Common stock at purchase price per share | $ / shares	$ 0.03

Income Taxes (Details)

Income Taxes (Details) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Income Taxes [Abstract]
Income tax benefit at U.S. statutory rate of 35%	$ (16,881)	$ (21,232)
Non-deductible interest	5,510	4,844
Change in valuation allowance	11,371	16,388
Total provision for income tax

Income Taxes (Details 1)

Income Taxes (Details 1) - USD ($)	Dec. 31, 2017	Dec. 31, 2016
Deferred Tax Asset:
Net operating loss carryforward	$ 122,537	$ 111,166
Valuation allowance	(122,537)	(111,166)
Net deferred tax asset

Income Taxes (Details Textual)

Income Taxes (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Income Taxes [Abstract]
Effective statutory rate, Percentage	35.00%
Net operating loss carryforward	$ 350,105
Operating loss carryforwards, Expiration date	Dec. 31, 2037
Change in valuation allowance	$ 11,371	$ 16,388